A 2-year-old child with moderate mitral stenosis secondary to rheumatic heart disease presents with dyspnea on exertion and recurrent respiratory tract infections. Echocardiography confirms a mitral valve area of 1.2 cm². Medical management is initiated to reduce symptoms and prevent complications. Which drug is the preferred first-line agent for rate control and symptom relief in this patient?

## Mitral Stenosis — Medical Management Strategy **Key Point:** Beta-blockers (propranolol) are the first-line agents for symptomatic mitral stenosis because they slow heart rate, prolong diastolic filling time, and reduce pulmonary congestion. ### Pathophysiology of Symptom Relief In mitral stenosis, the narrowed valve creates a fixed obstruction to left atrial emptying. Symptoms arise from: 1. **Elevated left atrial pressure** → pulmonary congestion (dyspnea) 2. **Reduced diastolic filling time** → decreased cardiac output Slowing heart rate (↑ diastolic time) allows more blood to cross the stenotic mitral valve, improving cardiac output and reducing LA pressure. ### Why Beta-Blockers (Propranolol) Are First-Line | Feature | Benefit | |---------|--------| | **Heart rate reduction** | ↑ Diastolic filling time across stenotic valve | | **Negative inotropy** | ↓ Myocardial oxygen demand | | **Negative chronotropy** | ↓ Pulmonary venous pressure | | **Symptom relief** | Improves exercise tolerance | | **Arrhythmia prevention** | Reduces AF risk (common in MS) | **Dosing:** Propranolol 0.5–1 mg/kg/day in divided doses (target HR 60–80 bpm at rest). ### Adjunctive Agents - **Diuretics (furosemide):** Used for pulmonary congestion but NOT monotherapy — they do not improve hemodynamics across the valve - **Digoxin:** Reserved for rate control in atrial fibrillation; less effective in sinus rhythm - **Calcium channel blockers (nifedipine):** Negative inotropes; contraindicated in MS with LV dysfunction **High-Yield:** The **ABCDE mnemonic** for MS management: - **A**void tachycardia (use beta-blockers) - **B**eta-blockers first-line - **C**ontrol AF (anticoagulation + rate control) - **D**iuretics for congestion - **E**ndocarditis prophylaxis **Clinical Pearl:** Calcium channel blockers (especially verapamil and diltiazem) are **contraindicated** in mitral stenosis because their negative inotropic effect worsens LV function and increases LA pressure. ### When to Consider Intervention - **Symptomatic MS** with valve area <1.5 cm² → percutaneous mitral valvotomy or surgical commissurotomy - **Severe MS** (area <1.0 cm²) → urgent intervention - **Failed medical management** → structural intervention **Warning:** Do NOT use nifedipine (dihydropyridine) or diltiazem as monotherapy in MS — they cause reflex tachycardia and worsen hemodynamics.